<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01550978</url>
  </required_header>
  <id_info>
    <org_study_id>HST-AG-04</org_study_id>
    <nct_id>NCT01550978</nct_id>
  </id_info>
  <brief_title>Evaluation of the Safety and Efficacy of the AnapnoGuard 100 System</brief_title>
  <official_title>The Safety of Using the AnapnoGuard 100 System in Intubated Critical Care Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospitech Respiration</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospitech Respiration</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety of using the AnapnoGuard 100 system
      during the course of mechanical ventilation and intubation of critical care patients in
      Intensive Care Unit.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of AE (adverse events) and SAE (serious adverse events)</measure>
    <time_frame>participants will be followed for the entire duration of intubation (an expected average of 8 days)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Intubation Complications</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients intubated with AnapnoGuard EndoTracheal Tube and connected to the AnapnoGuard 100 Control System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients intubated with the Standard of Care EndoTracheal Tube and Connected to a Suction Regulator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AnapnoGuard 100 System</intervention_name>
    <description>AnapnoGuardâ„¢ 100 Respiratory Guard System is intended for airway management by oral/nasal intubation while providing continuous endotracheal cuff pressure control using non-invasive measurement and monitoring of carbon dioxide concentration in the subglottic space and evacuation of secretions from above the endotracheal tube's cuff.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age above 21 (men and women);

          -  Patient is admitted to ICU and expected to receive mechanical ventilation for more
             than 12 hours

          -  Absence of clear signs of pneumonia and lung contusion on chest X ray;

          -  For study patients, connection of the ETT to the AnapnoGuard system less than 6 hours
             from intubation initiation;

          -  No fever or fever from a known non chest/lung origin;

        Exclusion Criteria:

          -  Patients who had been treated with mechanical ventilation during the last 3 months;

          -  Patients with facial, oropharyngeal or neck trauma

          -  BMI &gt; 40

          -  Pregnant women

          -  Patients ventilated in prone position

          -  Difficult intubation (defined as more than 3 intubation attempts)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo Antonelli, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director of General ICU and Institute of Anesthesiology and Intensive Care, Policlinico Universitario A. Gemelli</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Policlinico Universitario A. Gemelli</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2012</study_first_submitted>
  <study_first_submitted_qc>March 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 12, 2012</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

